123 filings
8-K
ANVS
Annovis Bio Inc
26 Apr 24
Entry into a Material Definitive Agreement
8:14am
10-K
2023 FY
ANVS
Annovis Bio Inc
Annual report
29 Mar 24
5:12pm
8-K
ANVS
Annovis Bio Inc
22 Mar 24
Other Events
5:24pm
8-K
ANVS
Annovis Bio Inc
21 Mar 24
Entry into a Material Definitive Agreement
5:23pm
8-K
ANVS
Annovis Bio Inc
20 Mar 24
Annovis Bio Provides Data Announcement Update for the Phase Ii/iii Study of Buntanetap In Alzheimer’s Disease
4:43pm
8-K
2lbbty0s
19 Mar 24
Other Events
9:20pm
424B5
zh0jbfp9
18 Mar 24
Prospectus supplement for primary offering
10:00pm
424B5
bx78z79l7tnh ngevws
18 Mar 24
Prospectus supplement for primary offering
8:51pm
8-K
m7vl04eu60i
15 Mar 24
Entry into a Material Definitive Agreement
5:22pm
EFFECT
c8jx nob934d
13 Feb 24
Notice of effectiveness
12:15am
CORRESP
85i3yy82xmvh8 ob98rp
9 Feb 24
Correspondence with SEC
12:00am
UPLOAD
inh2vil 5qexsogeva5g
5 Feb 24
Letter from SEC
12:00am
8-K
sxyxv p97cbp2z1y
1 Nov 23
Annovis Bio Announces Launch of Proposed Public Offering
12:28pm
424B5
i4y6mlzixw4o7 0v
1 Nov 23
Prospectus supplement for primary offering
12:24pm
424B5
hla4tj6
30 Oct 23
Prospectus supplement for primary offering
5:27pm
8-K
ct0j2rnydoggi5f08rp
30 Oct 23
Other Events
5:17pm
8-K
y7mhbmhb
12 Oct 23
ANNOVIS BIO ANNOUNCES POSITIVE interim INDEPENDENT analysis For STATISTICAL POWER IN its Alzheimer’s study
7:39pm